Maha Radhakrishnan

Insider Reports History

Location
C/O Alto Neuroscience, Inc., 369 South San Antonio Road, Los Altos, CA
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Maha Radhakrishnan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Maha Radhakrishnan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alto Neuroscience, Inc. Director Stock Option (right to buy) 1.59K $5.04K $3.17 Mar 8, 2024 Direct
Entrada Therapeutics, Inc. Director Stock Option (Right to Buy) 38K Jun 1, 2025 Direct
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 28.5K Jun 4, 2025 Direct

Insider Reports Filed by Maha Radhakrishnan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Jun 4, 2025 1 $0 4 Jun 6, 2025 Director
CADL Candel Therapeutics, Inc. Jun 4, 2025 0 $0 3 Jun 6, 2025 Director
TRDA Entrada Therapeutics, Inc. Jun 1, 2025 1 $0 4 Jun 3, 2025 Director
TRDA Entrada Therapeutics, Inc. Jun 1, 2025 0 $0 3 Jun 3, 2025 Director
ANRO Alto Neuroscience, Inc. Mar 8, 2024 2 $16.2K 4 Mar 12, 2024 Director
ANRO Alto Neuroscience, Inc. Mar 8, 2024 0 $0 3 Mar 12, 2024 Director